Loading
PDBj
メニューPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

2OF2

crystal structure of furanopyrimidine 8 bound to lck

2OF2 の概要
エントリーDOI10.2210/pdb2of2/pdb
関連するPDBエントリー2OF4
分子名称Proto-oncogene tyrosine-protein kinase LCK, 2,3-DIPHENYL-N-(2-PIPERAZIN-1-YLETHYL)FURO[2,3-B]PYRIDIN-4-AMINE (3 entities in total)
機能のキーワードlck, kinase domain, transferase
由来する生物種Homo sapiens (human)
細胞内の位置Cytoplasm: P06239
タンパク質・核酸の鎖数1
化学式量合計31744.39
構造登録者
Martin, M.W. (登録日: 2007-01-02, 公開日: 2007-02-27, 最終更新日: 2023-08-30)
主引用文献Martin, M.W.,Newcomb, J.,Nunes, J.J.,Bemis, J.E.,McGowan, D.C.,White, R.D.,Buchanan, J.L.,Dimauro, E.F.,Boucher, C.,Faust, T.,Hsieh, F.,Huang, X.,Lee, J.H.,Schneider, S.,Turci, S.M.,Zhu, X.
Discovery of novel 2,3-diarylfuro[2,3-b]pyridin-4-amines as potent and selective inhibitors of Lck: Synthesis, SAR, and pharmacokinetic properties.
Bioorg.Med.Chem.Lett., 17:2299-2304, 2007
Cited by
PubMed Abstract: 2,3-Diarylfuro[2,3-b]pyridine-4-amines are a novel class of potent and selective inhibitors of Lck. The discovery, synthesis, and structure activity relationships of this series of inhibitors are reported. The most promising compounds were also profiled to deduce their pharmacokinetic properties.
PubMed: 17276681
DOI: 10.1016/j.bmcl.2007.01.048
主引用文献が同じPDBエントリー
実験手法
X-RAY DIFFRACTION (2 Å)
構造検証レポート
Validation report summary of 2of2
検証レポート(詳細版)ダウンロードをダウンロード

249697

件を2026-02-25に公開中

PDB statisticsPDBj update infoContact PDBjnumon